DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Poon MC.
Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.
Vasc Health Risk Manag 2007;
3 (05) 655-664
Access:
We do not assume any responsibility for the contents of the web pages of other providers.